Related references
Note: Only part of the references are listed.Effects of Supplementary Seleno-L-methionine on Atopic Dermatitis-Like Skin Lesions in Mice
Tomohiro Arakawa et al.
BIOLOGICAL & PHARMACEUTICAL BULLETIN (2018)
Combinatorial immunotherapy for melanoma
D. D. George et al.
CANCER GENE THERAPY (2017)
Topical immunotherapy with diphencyprone (DPCP) for in-transit and unresectable cutaneous melanoma lesions: an inaugural Canadian series
Carrie Yeung et al.
EXPERT REVIEW OF CLINICAL IMMUNOLOGY (2017)
Dead Tumor Cells Expressing Infectious Salmon Anemia Virus Fusogenic Protein Favor Antigen Cross-Priming In Vitro
Jonathan Morales et al.
FRONTIERS IN IMMUNOLOGY (2017)
Effective Clinical Responses in Metastatic Melanoma Patients after Vaccination with Primary Myeloid Dendritic Cells
Gerty Schreibelt et al.
CLINICAL CANCER RESEARCH (2016)
Immunomodulation of malignant melanoma by contact sensitizing agents
Ryan M. Trowbridge et al.
EXPERT REVIEW OF CLINICAL IMMUNOLOGY (2014)
Topical Immunotherapy with Diphencyprone for in Transit and Cutaneously Metastatic Melanoma
Diona L. Damian et al.
JOURNAL OF SURGICAL ONCOLOGY (2014)
Hapten-Induced Contact Hypersensitivity, Autoimmune Reactions, and Tumor Regression: Plausibility of Mediating Antitumor Immunity
Dan A. Erkes et al.
JOURNAL OF IMMUNOLOGY RESEARCH (2014)
The immunological response and post-treatment survival of DC-vaccinated melanoma patients are associated with increased Th1/Th17 and reduced Th3 cytokine responses
Claudia Duran-Aniotz et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2013)
Natural Human Plasmacytoid Dendritic Cells Induce Antigen-Specific T-Cell Responses in Melanoma Patients
Jurjen Tel et al.
CANCER RESEARCH (2013)
Immuno-oncology: understanding the function and dysfunction of the immune system in cancer
O. J. Finn
ANNALS OF ONCOLOGY (2012)
Keratinocyte-derived Laminin-332 Promotes Adhesion and Migration in Melanocytes and Melanoma
Heesung Chung et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Lipopolysaccharide Inhibits the Channel Activity of the P2X7 Receptor
Elias Leiva-Salcedo et al.
MEDIATORS OF INFLAMMATION (2011)
PD-1 and CTLA-4 combination blockade expands infiltrating T cells and reduces regulatory T and myeloid cells within B16 melanoma tumors
Michael A. Curran et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Topical diphencyprone immunotherapy for cutaneous metastatic melanoma
Diona L. Damian et al.
AUSTRALASIAN JOURNAL OF DERMATOLOGY (2009)
Effect of litreol on the viability of human cancer cells
Alessandra Russo et al.
CHEMICO-BIOLOGICAL INTERACTIONS (2009)
Prolonged Survival of Dendritic Cell-Vaccinated Melanoma Patients Correlates With Tumor-Specific Delayed Type IV Hypersensitivity Response and Reduction of Tumor Growth Factor β-Expressing T Cells
Mercedes N. Lopez et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Allergic and irritant contact dermatitis Pathophysiology and immunological diagnosis
Audrey Nosbaum et al.
EUROPEAN JOURNAL OF DERMATOLOGY (2009)
Tumor-specific Th17-polarized cells eradicate large established melanoma
Pawel Muranski et al.
BLOOD (2008)
Treatment of metastatic melanoma using interleukin-2 alone or in conjunction with vaccines
Franz O. Smith et al.
CLINICAL CANCER RESEARCH (2008)
Chemoimmunotherapy for melanoma with dacarbazine and 2,4-dinitrochlorobenzene elicits a specific T cell-dependent immune response
C Wack et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2002)
Treatment of metastatic melanoma with autologous, hapten-modified melanoma vaccine: Regression of pulmonary metastases
D Berd et al.
INTERNATIONAL JOURNAL OF CANCER (2001)
Synergism of cytotoxic T lymphocyte-associated antigen 4 blockade and depletion of CD25+ regulatory T cells in antitumor therapy reveals alternative pathways for suppression of autoreactive cytotoxic T lymphocyte responses
RPM Sutmuller et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2001)
Immunopathogenesis of delayed-type hypersensitivity
K Kobayashi et al.
MICROSCOPY RESEARCH AND TECHNIQUE (2001)
Share Paper
